Skip to main content
. 2017 Jan 12;19(2):100–111. doi: 10.1016/j.neo.2016.12.009

Fig. 4.

Fig. 4

Abnormal DNA methylation of TEs. (A) Percentage of methylation shifts in different classes of TEs across uterine cancers compared to normal endometrium. (B and C) Percentage of hypomethylated DMRs overlapping TEs in UCS. (D) Epigenome Browser views of three subfamilies of TEs (LTR12C, L1PA2, and L1PA3). MethylCRF scores across different uterine cancers are displayed.